Clinical trial
Generic vs. Name-Brand Levothyroxine
NCT00403390 · Boston Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00403390 |
|---|---|
| Title | Generic vs. Name-Brand Levothyroxine |
| Official title | Generic vs. Name-Brand Levothyroxine: Assessment of Bioequivalence Using TSH as a Marker in Children With Permanent Hypothyroidism |
| Lead sponsor | Boston Children's Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Congenital Hypothyroidism, Hypothyroidism |
| Intervention type | Drug |
| Interventions | Brand Name Levothyroxine (Synthroid), Generic formulation of Levothyroxine |
| Enrollment | 34 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Nov 23, 2006 |
| Last update posted | Feb 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: